SEQ_NO 2 Date of announcement 2024/01/10 Time of announcement 17:04:04 Subject Announcement to correct the company’s statements of endorsements and guarantees in November 2023. Date of events 2024/01/10 To which item it meets paragraph 51 Statement 1.Date of occurrence of the event:2024/01/10 2.Company name:Excelsior Medical Co.,Ltd 3.Relationship with the Company (please enter ”the company …
Item Net Revenue 2023.12 727,021 2022.12 675,492 MoM Change 51,529 MoM Change (%) 7.63 2023 1-12 8,232,513 2022 1-12 7,186,654 YoY Change 1,045,859 YoY Change (%) 14.55 Note
SEQ_NO 3 Date of announcement 2023/12/29 Time of announcement 17:38:06 Subject Announcement on behalf of major subsidiary, Excelsior Asset Management Co., Ltd., regarding the change of general manager. Date of events 2023/12/29 To which item it meets paragraph 6 Statement 1.Date of the board of directors resolution or date of occurrence of the change: …
SEQ_NO 2 Date of announcement 2023/12/29 Time of announcement 17:37:28 Subject To announce the change of deputy general manager of the company. Date of events 2023/12/29 To which item it meets paragraph 8 Statement 1.Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.),financial officer, accounting officer, corporate …
To announce the change of deputy general manager of the company. Read More »
SEQ_NO 1 Date of announcement 2023/12/29 Time of announcement 17:36:38 Subject To announce the change of acting spokesperson of the company. Date of events 2023/12/29 To which item it meets paragraph 8 Statement 1.Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.),financial officer, accounting officer, corporate governance …
To announce the change of acting spokesperson of the company. Read More »
Item Net Revenue 2023.10 679,954 2022.10 633,490 MoM Change 46,464 MoM Change (%) 7.33 2023 1-10 6,728,401 2022 1-10 5,857,177 YoY Change 871,224 YoY Change (%) 14.87 Note
SEQ_NO 1 Date of announcement 2023/11/07 Time of announcement 18:07:38 Subject The Board of Directors approved Q3 2023 consolidated financial statements. Date of events 2023/11/07 To which item it meets paragraph 31 Statement 1.Date of submission to the board of directors or approval by the board of directors:2023/11/07 2.Date of approval by the audit …
The Board of Directors approved Q3 2023 consolidated financial statements. Read More »
Item Net Revenue 2023.09 705,001 2022.09 643,396 MoM Change 61,605 MoM Change (%) 9.57 2023 1-9 6,048,447 2022 1-9 5,223,687 YoY Change 824,760 YoY Change (%) 15.79 Note
2023/04/27 2023/09/21
SEQ_NO 1 Date of announcement 2023/09/20 Time of announcement 17:39:56 Subject The Company is invited to attend an institutional investor conference hosted by President Securities on September 21, 2023. Date of events 2023/09/20 To which item it meets paragraph 12 Statement 1.Date of institutional investor conference:2023/09/21 2.Time of institutional investor conference:16:20 3.Location of institutional …
